Clinical Trial Update: Evaluation of the Efficacy of the Bipolar Sealer Aquamantys 6.0 in Patients Undergoing Total Hip Arthroplasty [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of the Aquamantys 6.0 bipolar sealer during total hip arthroplasty; results were posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hip Osteoarthritis

Drugs mentioned

• Aquamantys 6.0 bipolar sealer

Snippet

Sponsor: The Cleveland Clinic | Conditions: Hip Arthritis | Phase 4 | Status: COMPLETED | Results posted: 2012-11-29